Showing 5081-5090 of 5355 results for "".
- Renaissance and GlaxoSmithKline Transfer Nine Productshttps://practicaldermatology.com/news/20130605-renaissance_and_glaxosmithkline_transfer_nine_products/2459522/Renaissance Acquisition Holdings, LLC and GlaxoSmithKline entered into an agreement giving Renaissance the rights in the USA to manufacture, market, and sell six dermatology and three anti-viral products from GSK. The products from GSK and Stiefel, which will be marketed through Renaissance's bran
- Results of SB204 Clinical Study in Acne Releasedhttps://practicaldermatology.com/news/20130605-results_of_sb204_clinical_study_in_acne_released/2459523/Nitric oxide releasing drug candidate SB204 reduces colonization of the acne-causing bacteria Propionibacterium acnes (P. acnes) in the skin of healthy volunteers, according to a recent trial. This study, in combination with Novan Therapeutics' earlier findings regarding sebum production, suggests t
- Levia Targeted Phototherapy Now Part of Daavlinhttps://practicaldermatology.com/news/20130531-levia_targeted_phototherapy_now_part_of_daavlin/2459525/Daavlin has been appointed by Lerner Medical Devices to exclusively manufacture, sell, and support their Levia Targeted Home Phototherapy Device. The Levia device complements Daavlin's line of home units for the treatment of skin disorders such as psoriasis, vitiligo, and eczema. Product warranties
- New Technical Manager at Jurliquehttps://practicaldermatology.com/news/20130531-new_technical_manager_at_jurlique/2459527/Jurlique appointed Connie Lim to Technical Manager of Global Product Development. In her new role, Ms. Lim will drive innovative formula development, provide technical support, and monitor performance and key milestones in global new product development efforts. Ms. Lim comes to Jurlique with mor
- Two Melanoma Drugs Win FDA Approvalhttps://practicaldermatology.com/news/20130530-two_melanoma_drugs_win_fda_approval/2459528/The FDA approved two new drugs for metastatic or inoperable melanoma, dabrafenib (Tafinlar) and trametinib (Mekinist). Dabrafenib is an inhibitor of the BRAF gene when it carries the so-called V600E mutation. Trametinib inhibits a target known as MEK and is effective primarily against melanomas carr
- Skin Health Seminars to Begin Next Monthhttps://practicaldermatology.com/news/20130522-skin_health_seminars_to_begin_next_month/2459532/ZO Skin Health, Inc. will host a series of educational seminars and webinars on “Expanded Concepts and Principles of Skin Health Science,” created and presented by Zein Obagi, MD, and board-certified dermatologist Monika Kiripolsky, MD. Each seminar plans to educate skincare professionals and cons
- Clark Pharmaceuticals, Ferndale Healthcare Launch DerMendhttps://practicaldermatology.com/news/20130521-clark_pharmaceuticals_ferndale_healthcare_launch_dermend/2459534/Clark Pharmaceuticals partnered with Ferndale Healthcare to launch DerMend Moisturizing Bruise Formula. The formula is predicated on the idea that skin over 50 tends to get thinner and bruises more easily. Blood thinners, even those like low-dose baby aspirin, can cause skin to bruise. DerMend is de
- AMA Foundation Awards Research Grants To Study Issues Affecting Women In Medicinehttps://practicaldermatology.com/news/20130521-ama_foundation_awards_research_grants_to_study_issues_affecting_women_in_medicine/2459535/In 1850, the first medical institution in the world established to train women in medicine and offer opportunities of an MD opened their doors in Philadelphia. For those women, it was a chance to enter the medical world that routinely shut them out. While women today don't face such a task, importan
- AARS and AAP Release Acne Recommendationshttps://practicaldermatology.com/news/20130520-aars_and_aap_release_acne_recommendations/2459536/Evidence-based recommendations for the diagnosis and treatment of pediatric acne were recently published in Pediatrics. These recommendations were developed through the American Acne Rosacea Society (AARS) and endorsed by the American Academy of Pediatrics. The recommendations are a result of a two
- Anti-bacterial Soap Under FDA Reviewhttps://practicaldermatology.com/news/20130520-anti-bacterial_soap_under_fda_review/2459537/The Food and Drug Administration (FDA) is studying whether triclosan is safe and effective. The FDA's findings could have implications for a $1 billion industry that includes hundreds of anti-bacterial soaps and body washes, particularly in acne washes. The review comes amid recent studies that have